tag:blogger.com,1999:blog-16774010.post2542583413619221122..comments2024-01-25T17:58:34.297-05:00Comments on Scott's Web Log: The Business of Diabetes: Indy Star Reports that "Lilly returns to its roots" (in diabetes)Scott Shttp://www.blogger.com/profile/03286529314567223617noreply@blogger.comBlogger6125tag:blogger.com,1999:blog-16774010.post-55430361870618308542008-03-17T22:27:00.000-04:002008-03-17T22:27:00.000-04:00Donna, It is sad and I cannot help but wonder what...Donna, It is sad and I cannot help but wonder what Col. Eli Lilly would think about how the company has been managed? My suspicion is he might be impressed with the growth, but sorry about some of the bone-headed decisions the last CEO made by letting things decline this fast in the diabetes business, or how patients have been disregarded. I'm not too optimistic about the current heir-apparent, but we shall find out ...Scott Shttps://www.blogger.com/profile/03286529314567223617noreply@blogger.comtag:blogger.com,1999:blog-16774010.post-84697894703573795052008-03-17T21:36:00.000-04:002008-03-17T21:36:00.000-04:00Unfortunately, for the little people who work at L...Unfortunately, for the little people who work at Lilly's, the big shots at Lilly are the ones making such bad decisions. I have family members who are the little people at Lilly - the workers who depend on Lilly for their income, insurance, etc. When a big company starts having problems, I start at the top with the blame. In this situation, they are not only hurting people who rely on them for their pharmaceuticals, but by doing this, they could also be untimatley hurting those workers who do the job. It's sad....Donnahttps://www.blogger.com/profile/03072030400404976772noreply@blogger.comtag:blogger.com,1999:blog-16774010.post-6371596901777661562008-03-17T15:17:00.000-04:002008-03-17T15:17:00.000-04:00The whole Zyprexa issue is a sad travesty of ethic...The whole Zyprexa issue is a sad travesty of ethics. I, like many others, am watching the Alaska lawsuit with great interest, and now we can add Connecticut to the list. About 2 weeks ago, Connecticut's Attorney General Richard Blumenthal announced the state was suing Eli Lilly over the marketing of Zyprexa on the grounds that Lilly illegally marked the drug for unapproved uses and concealed risks associated with the drug. Of course, I also want to see that the FDA's proposed loosening of off-label marketing does is not allowed, or we'd see more of this, with no hope for recourse for the victims.<BR/><BR/>The reality is that Lilly has neglected this business for over a decade, and is forced to invest in it because its in such bad shape today. But whether they can do anything about it before their patents start expiring remains to be seen!Scott Shttps://www.blogger.com/profile/03286529314567223617noreply@blogger.comtag:blogger.com,1999:blog-16774010.post-35682835648593825002008-03-17T15:07:00.000-04:002008-03-17T15:07:00.000-04:00Eli Lilly needs to do something since they did cau...Eli Lilly needs to do something since they did cause diabetes in so many people with Zyprexa. I have first hand knowledge with that as I am one of them diagnosed with it after I was put on it. And now I take Eli Lilly's insulin. Granted I am getting a lawsuit settlement out of them, but thanks to them I get to deal with a lifetime of complications now.Anonymoushttps://www.blogger.com/profile/12663834970840698294noreply@blogger.comtag:blogger.com,1999:blog-16774010.post-44050504279905651662008-03-17T14:39:00.000-04:002008-03-17T14:39:00.000-04:00Scott--I believe it is unquestionable that (at lea...Scott--<BR/><BR/>I believe it is unquestionable that (at least until recently) most Type 2's were NOT children. But does analyst Funtleyder's unqualified statement that most Type 1's are children sound just a bit off-target?<BR/><BR/>And while he contends that this 'unmet need' [is] 'kind of sad because most of the patients are children' . . . why doesn't he speak to the real travesty: these same children can expect to grow into adulthood with the same needs still unmet! <BR/><BR/>MelodyAnonymousnoreply@blogger.comtag:blogger.com,1999:blog-16774010.post-14633517331683737612008-03-17T13:25:00.000-04:002008-03-17T13:25:00.000-04:00Let's not forget Lilly's most creative way to expa...Let's not forget Lilly's most creative way to expand its diabetes business, by aggressively promoting Zyprexa off label in a way that created thousands of new cases of diabetes, particularly in the young people Lilly pretends to care for so much.<BR/><BR/>The data on how Lilly convinced doctors to prescribe Zyprexa off label has been coming out in a lawsuit, and company emails laying out the strategy make it crystal clear it was intentional.<BR/><BR/>I saw Zyprexa turn a friend's previously thin, normal teenager into a diabetic blimp--a teen who was troubled, but by no stretch of the imagination schizophrenic. So I know first hand what the toll of this drug has been. <BR/><BR/>That the company's executives suppressed the information that Zyprexa causes diabetes and pushed it on teens tells you all you need to know about their ethics.Jennyhttps://www.blogger.com/profile/17384082448952856117noreply@blogger.com